INDRAMEDCO
INDRAPRASTHA MEDICAL CORP
Each stock's 10,000-path forecast, rendered as light.
INDRAPRASTHA MEDICAL CORP (INDRAMEDCO) Stock Analysis & Case Study
Is INDRAMEDCO a good buy? The data-driven verdict.
on the numbers it mixed signals, a Downstox Snapshot Score of 45/100.
On the numbers, INDRAPRASTHA MEDICAL CORP (INDRAMEDCO) mixed signals, a Downstox Snapshot Score of 45/100, weighing a 57% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
INDRAMEDCO share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of INDRAMEDCO history (21%/yr drift, 50%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| INDRAMEDCO 2027 | ₹220 | ₹416 | ₹781 | +9% |
| INDRAMEDCO 2028 | ₹184 | ₹456 | ₹1,111 | +19% |
| INDRAMEDCO 2029 | ₹162 | ₹492 | ₹1,482 | +28% |
| INDRAMEDCO 2030 | ₹154 | ₹547 | ₹1,910 | +43% |
| INDRAMEDCO 2031 | ₹141 | ₹587 | ₹2,423 | +53% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability INDRAMEDCO goes up, or doubles?
The bull case for INDRAMEDCO
- INDRAPRASTHA MEDICAL CORP is part of the NSE universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹1,482.
The bear case & risks
- High historical volatility (50%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹162.
INDRAMEDCO volatility & expected range, how bumpy is the ride?
Over the last 2.0 years INDRAMEDCO compounded at 21%/year with annualized volatility of 50%. That volatility implies a 1-year 80% range of ₹220–₹781, the honest backbone behind any single price target.
INDRAMEDCO price forecast, the full 60-month probability fan
INDRAMEDCO price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds INDRAMEDCO hits common targets within the simulated horizon?
Full multi-horizon detail on the INDRAMEDCO price target & forecast page.
INDRAMEDCO MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy INDRAMEDCO with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| UpstoxCHEAPEST | 36.4% | 2.7× |
| ZerodhaCHEAPEST | 36.4% | 2.7× |
| DhanCHEAPEST | 36.4% | 2.7× |
Compare every broker on the INDRAMEDCO MTF page.
INDRAMEDCO vs peers,sector comparison
About INDRAPRASTHA MEDICAL CORP: sector, index & market-cap context
INDRAPRASTHA MEDICAL CORP (INDRAMEDCO) is an NSE-listed company.
How the INDRAMEDCO Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of INDRAPRASTHA MEDICAL CORP's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
INDRAMEDCO analysis, FAQs
Is INDRAPRASTHA MEDICAL CORP (INDRAMEDCO) a good buy?
On the numbers, INDRAPRASTHA MEDICAL CORP (INDRAMEDCO) mixed signals, a Downstox Snapshot Score of 45/100, weighing a 57% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is INDRAMEDCO overvalued or undervalued?
Valuation ratios for INDRAMEDCO are tracked live on Downstox.
What is the INDRAMEDCO share price target for 2031?
INDRAMEDCO's probability-weighted 2031 median target is ₹587, with an 80% range of ₹141–₹2,423 (10,000-path Monte-Carlo).
What is the probability INDRAMEDCO doubles in 5 years?
The modelled probability of INDRAMEDCO reaching ₹766 (2×) within 5 years is 41%.
What is the bull case for INDRAMEDCO?
INDRAPRASTHA MEDICAL CORP is part of the NSE universe with live, tracked fundamentals on Downstox.
What are the risks in INDRAMEDCO?
High historical volatility (50%/yr) means a wide, bumpy range of outcomes, size positions accordingly.